$32.08
-0.83-2.52%
MERCK KGAA SPNS/ADR by Merck KGaA (MKKGY) Stock Price, Quote, News & History
MKKGYOTCPK
Silence Therapeutics (SLN) leaps 126% on a $1.3B cash acquisition by Merck KGaA at $20 per ADS. Deal expected to close Q1 2027.
You can purchase shares of MERCK KGAA SPNS/ADR by Merck KGaA (OTCPK:MKKGY) through any online brokerage.
There are no as such competitors for MERCK KGAA SPNS/ADR by Merck KGaA.
There is no analysis for MERCK KGAA SPNS/ADR by Merck KGaA to provide a consensus price target.
The stock price for MERCK KGAA SPNS/ADR by Merck KGaA (OTCPK: MKKGY) is $ last updated .
There are no upcoming dividends for MERCK KGAA SPNS/ADR by Merck KGaA.
MERCK KGAA SPNS/ADR by Merck KGaA does not have any upcoming earnings scheduled.
There is no upcoming split for MERCK KGAA SPNS/ADR by Merck KGaA.
MERCK KGAA SPNS/ADR by Merck KGaA is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Merck KGaA operates in three main segments: life science, electronics, and healthcare. The life science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry....
